참고문헌
- Anders CK, Hsu DS, Broadwater G, et al (2008). Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol, 26, 3324-30. https://doi.org/10.1200/JCO.2007.14.2471
- Cancello G, Maisonneuve P, Rotmensz N, et al (2010). Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol, 21, 1974-81. https://doi.org/10.1093/annonc/mdq072
- Dubsky PC, Gnant MF, Taucher S, et al (2002). Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer, 3, 65-72. https://doi.org/10.3816/CBC.2002.n.013
- Evans AJ, Pinder SE, James JJ, et al (2006). Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer? AJR Am J Roentgenol, 187, 1377-80. https://doi.org/10.2214/AJR.05.0725
- Falck AK, Ferno M, Bendahl PO, et al (2013). St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases-aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial. BMC Cancer, 13, 558. https://doi.org/10.1186/1471-2407-13-558
- Goodman S, O'Connor A, Kandil D, et al (2014). The ever-changing role of sentinel lymph node biopsy in the management of breast cancer. Arch Pathol Lab Med, 138, 57-64. https://doi.org/10.5858/arpa.2012-0441-RA
- Guarneri V, Dieci MV, Barbieri E, et al (2013). Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients. Ann Oncol, 24, 2990-4. https://doi.org/10.1093/annonc/mdt364
- James JJ, Evans AJ, Pinder SE, et al (2003). Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers? Clin Radiol, 58, 54-62.
- Karimi A, Delpisheh A, Sayehmiri K, et al (2014). Predictive factors of survival time of breast cancer in Kurdistan Province of Iran between 2006-2014: A Cox regression approach. Asian Pac J Cancer Prev, 15, 8483-8. https://doi.org/10.7314/APJCP.2014.15.19.8483
- Malik HZ, Wilkinson L, George WD, et al (2000). Preoperative mammographic features predict clinicopathological risk factors for the development of local recurrence in breast cancer. Breast, 9, 329-33. https://doi.org/10.1054/brst.1999.0148
- Mansson E, Bergkvist L, Christenson G, et al (2009). Mammographic casting-type calcifications is not a prognostic factor in unifocal small invasive breast cancer: a population-based retrospective cohort study. J Surg Oncol, 100, 670-4. https://doi.org/10.1002/jso.21405
- Peacock C, Given-Wilson R, Duffy S (2004). Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator? Clin Radiol, 59, 855. https://doi.org/10.1016/j.crad.2004.06.009
- Schwartz AM, Henson DE, Chen D, et al (2014). Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER program. Arch Pathol Lab Med, 138, 1048-52. https://doi.org/10.5858/arpa.2013-0435-OA
- Tabar L, Chen HH, Duffy SW, et al (2000). A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet, 355, 429-33. https://doi.org/10.1016/S0140-6736(00)82008-5
- Tabar L, Tony Chen HH, Amy Yen MF, et al (2004). Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer, 101, 1745-59. https://doi.org/10.1002/cncr.20582
- Thapa B, Singh Y, Sayami P, et al (2013). Breast cancer in young women from a low risk population in Nepal. Asian Pac J Cancer Prev, 14, 5095-9. https://doi.org/10.7314/APJCP.2013.14.9.5095
- Thurfjell E, Thurfjell MG, Lindgren A (2001). Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat, 67, 177-80. https://doi.org/10.1023/A:1010648919150
- Victorino VJ, Campos FC, Herrera AC, et al (2014). Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer. Tumour Biol, 35, 3025-34. https://doi.org/10.1007/s13277-013-1391-x
- Zunzunegui RG, Chung MA, Oruwari J, et al (2003). Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Arch Surg, 138, 537-40. https://doi.org/10.1001/archsurg.138.5.537